본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Association of polypharmacy with all-cause mortality and adverse events among elderly colorectal cancer survivors
()

CHOI DONG WOO
(Data Link & Operation Team)
. Association of polypharmacy with all-cause mortality and adverse events among elderly colorectal cancer survivors. CANCER. 2023-04-28; 2023; :~. IF 6.2 (2022)
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M-positive non-small cell lung cancer Han Ji-Youn
(Anticancer Resistance Branch )


()
. Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M-positive non-small cell lung cancer. CANCER MEDICINE. 2023-04-25; 2023; 12(11):12285~12298. IF 4 (2022)
Changes in cervical dysplasia, carcinoma in situ, and cervical cancer after expanding the National Cancer Screening Program to younger women in Korea
()

Kim Woo Rim
(Division of Cancer Management Policy)
. Changes in cervical dysplasia, carcinoma in situ, and cervical cancer after expanding the National Cancer Screening Program to younger women in Korea. INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE. 2023-04-25; 2023; 35(2):1~6. IF 2.6 (2022)
Perioperative systemic therapy in muscle invasive bladder cancer: Current standard, biomarkers and emerging strategies Seo Ho Kyung
(Immuno-oncology Branch)


()
. Perioperative systemic therapy in muscle invasive bladder cancer: Current standard, biomarkers and emerging strategies. INVESTIGATIVE AND CLINICAL UROLOGY. 2023-04-24; 2023; 64(3):202~218. IF 2.3 (2022)
Lazertinib in pretreated EGFR T790M-mutated advanced non-small celllung cancer: A real-world multicenter study
()

Ahn Beung Chul
(Branch of Hemato Oncology)
. Lazertinib in pretreated EGFR T790M-mutated advanced non-small celllung cancer: A real-world multicenter study. LUNG CANCER. 2023-04-21; 2023; 180:107213~. IF 5.3 (2022)
Association between inflammatory potential of diet and periodontitis disease risks: Results from a Korean population-based cohort study Kim Mi Kyung
(Cancer Epidemiology Branch)

Choi Sung Weon
(Rare & Pediatric Cancer Branch)
. Association between inflammatory potential of diet and periodontitis disease risks: Results from a Korean population-based cohort study. JOURNAL OF CLINICAL PERIODONTOLOGY. 2023-04-21; 2023; 50(7):952~963. IF 6.7 (2022)
The lived experience of colorectal cancer patients with a temporary ileostomy and the patient’s perception of the ostomy nurses’ educational interventions Kim, Young Ae
(Division of Cancer Management Policy)


()
. The lived experience of colorectal cancer patients with a temporary ileostomy and the patient’s perception of the ostomy nurses’ educational interventions. SUPPORTIVE CARE IN CANCER. 2023-04-18; 2023; 31(5):276~. IF 3.1 (2022)
Effect of Lactobacillus Rhamnosus GG for Regulation of Inflammatory Response in Radiation-Induced Enteritis
()

Lee Sung Uk
(Department of Radiation oncology)
. Effect of Lactobacillus Rhamnosus GG for Regulation of Inflammatory Response in Radiation-Induced Enteritis. PROBIOTICS AND ANTIMICROBIAL PROTEINS. 2023-04-18; 2023; Online:Published. IF 4.9 (2022)
Postoperative inpatient exercise facilitates recovery after laparoscopic surgery in colorectal cancer patients: a randomized controlled trial
()

Min Ji Hee
(Cancer Survivorship Policy & Planning Team)
. Postoperative inpatient exercise facilitates recovery after laparoscopic surgery in colorectal cancer patients: a randomized controlled trial. BMC GASTROENTEROLOGY. 2023-04-17; 2023; 23(1):127~. IF 2.4 (2022)
Interaction between blood cadmium and lead concentration and physical activity on hypertension from the Korean national health and nutrition examination survey in 2008-2013
()

Kim Byung Mi
(Division of Cancer Prevention)
. Interaction between blood cadmium and lead concentration and physical activity on hypertension from the Korean national health and nutrition examination survey in 2008-2013. BMC PUBLIC HEALTH. 2023-04-17; 2023; 23(1):703~. IF 4.5 (2022)